Skip to main content
. 2012 Dec 31;2012:675310. doi: 10.5402/2012/675310

Figure 3.

Figure 3

Mean 15D dimension values of acromegalic patients grouped by need for SSA treatment at the time of the questionnaire. When in remission (GH remis.), all the 15D dimension values were comparable to the reference population (Ref popul.). In contrast, acromegalics with SSA treatment (GH medic.) had significantly more discomfort and distress in addition to decreased vitality and the 15D score (keybox) compared to the Ref. popul. 15D abbreviations are the same as in Figure 1. (*, P < 0.05) acromegalics on SSA treatment versus Ref. popul.